Democrats seek narrow path to rein in cost of prescription drugs
WASHINGTON President Joe Biden's call for authorizing Medicare to negotiate lower prescription drug prices has energized Democrats on a politically popular idea they've been pushing for nearly 20 years only to encounter frustration.
But they still lack a clear path to enact legislation. That's because a few Democrats remain uneasy over government price curbs on pharmaceutical companies.
House Speaker Nancy Pelosi and Senate Majority Leader Chuck Schumer will need every Democratic vote in a narrowly divided Congress. Otherwise, Democrats may have to settle for a compromise that stops short of their goal. Or they could take the question into the 2022 midterm elections.
"There is a path," said Rep. Peter Welch, D-Vt., one of Pelosi's lieutenants. "But there's also a challenge, and the challenge is we've got razor-thin margins."
https://www.msn.com/en-us/news/politics/democrats-seek-narrow-path-to-rein-in-cost-of-prescription-drugs/ar-BB1gjA7k